Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Class A common stock, par value $0.001 per share
-
Shares outstanding
-
66,027,379
-
Total 13F shares
-
16,130,676
-
Share change
-
-856,672
-
Total reported value
-
$118,562,071
-
Price per share
-
$7.35
-
Number of holders
-
52
-
Value change
-
-$6,299,411
-
Number of buys
-
19
-
Number of sells
-
21
Institutional Holders of Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX) as of Q4 2023
As of 31 Dec 2023,
Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,130,676 shares.
The largest 10 holders included
Cormorant Asset Management, LP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., CITADEL ADVISORS LLC, VANGUARD GROUP INC, FMR LLC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and HighVista Strategies LLC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.